What is Semaglutide?
Semaglutide is a medication used primarily for the treatment of type 2 diabetes and as a long-term therapy for weight management in individuals with obesity or overweight.
It is marketed under brand names such as Ozempic, Wegovy, and Rybelsus, and works by mimicking the hormone glucagon-like peptide-1 (GLP-1) to regulate blood sugar levels and appetite.
How does Semaglutide work?
Semaglutide is a GLP-1 receptor agonist, which means it binds to GLP-1 receptors in various tissues and produces effects similar to the natural hormone. Its mechanisms include:
1. Blood Sugar Regulation:
- Stimulates insulin secretion in response to high blood sugar levels.
- Suppresses glucagon release, which reduces glucose production by the liver.
- Improves insulin sensitivity.
2. Appetite and Weight Management:
- Reduces appetite by acting on brain centers that regulate hunger.
- Slows gastric emptying, making individuals feel full longer.
3. Cardiovascular Benefits:
- Reduces the risk of major adverse cardiovascular events (e.g., heart attack, stroke) in people with type 2 diabetes or cardiovascular disease.
How is Semaglutide Used?
Semaglutide has multiple approved indications:
1. Type 2 Diabetes:
- Improves glycemic control when combined with diet and exercise.
- Reduces cardiovascular risks in patients with established heart disease.
2. Weight Management:
- Approved for adults and adolescents (12 years or older) with obesity or overweight and related comorbidities (e.g., hypertension, dyslipidemia).
- Used alongside a reduced-calorie diet and increased physical activity.
3. Cardiovascular Health:
- Lowers the risk of cardiovascular events in individuals with diabetes or obesity.
4. Emerging Uses:
- Shows potential benefits for conditions like binge eating disorder, asthma, heart failure, and even reducing Alzheimer’s disease risk.
Semaglutide is typically administered as a weekly subcutaneous injection (Ozempic, Wegovy) or a daily oral tablet (Rybelsus).
